5-HT3受体拮抗剂
| 英文名 | Granisetron hydrochloride | CAS号 | 107007-99-8 |
| 试剂别名 |
HYDROCHLORIDE; BRL-43694A; GRANISERTROL HYDROCHLORIDE; GRANISETRON HCL; GRANISETRON HYDROCHLORIDE; GRANISTRON HYDROCHLORIDE; KYTRIL 1-methyl-n-(9-methyl-9-azabicyclo(3.3.1)non-3-yl)-1h-indazole-3-carboxamid; endo-1-methyl-n-(9-methyl-9-azabicyclo(3.3.1)non-3-yl)-1h-indazole-3-carboxa; endo-monohydrochlorid; midehydrochloride; GranisetronHclFda; GranisetronBase; GranisetronHydrochlorideFdaInspected; Granisertronhydrochloride; Granisetron hydrocholride; BRL-43694A, Kytril, 1-Methyl-N-[(3-endo)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-1H-indazole-3-carboxamide; Hydrochloride; 1H-Indazole-3-carboxamide, 1-methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-, monohydrochloride, endo- 1H-Indazole-3-carboxamide, 1-methyl-N-[(3-endo)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-, monohydrochloride; endo-monohydrochloride
|
分子式 | C18H24N4O.HCl |
| 产品编号 | APEA1295 | 分子量 | 348.87 |
| MDL号 | MFCD01747034 |
| 产品名称： | 5-HT3受体拮抗剂 |
| 英文名称： | Granisetron hydrochloride |
| 英文别名： | HYDROCHLORIDE; BRL-43694A; GRANISERTROL HYDROCHLORIDE; GRANISETRON HCL; GRANISETRON HYDROCHLORIDE; GRANISTRON HYDROCHLORIDE; KYTRIL 1-methyl-n-(9-methyl-9-azabicyclo(3.3.1)non-3-yl)-1h-indazole-3-carboxamid; endo-1-methyl-n-(9-methyl-9-azabicyclo(3.3.1)non-3-yl)-1h-indazole-3-carboxa; endo-monohydrochlorid; midehydrochloride; GranisetronHclFda; GranisetronBase; GranisetronHydrochlorideFdaInspected; Granisertronhydrochloride; Granisetron hydrocholride; BRL-43694A, Kytril, 1-Methyl-N-[(3-endo)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-1H-indazole-3-carboxamide; Hydrochloride; 1H-Indazole-3-carboxamide, 1-methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-, monohydrochloride, endo- 1H-Indazole-3-carboxamide, 1-methyl-N-[(3-endo)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-, monohydrochloride; endo-monohydrochloride |
| 中文别名： | 盐酸格拉司琼 |
| CAS No.： | 107007-99-8 |
| 分子式： | C18H24N4O.HCL |
| 分子量： | 348.87 |
| 危险品级别： | |
| HS符号： | |
| 危害声明： |
